NASDAQ:ACHV Achieve Life Sciences (ACHV) Stock Forecast, Price & News $4.30 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$4.24▼$4.4450-Day Range$4.30▼$5.6852-Week Range$2.00▼$10.30Volume49,478 shsAverage Volume43,135 shsMarket Capitalization$90.77 millionP/E RatioN/ADividend YieldN/APrice Target$18.67 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Achieve Life Sciences MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside334.1% Upside$18.67 Price TargetShort InterestBearish3.32% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.00Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.62) to ($1.61) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.93 out of 5 starsMedical Sector706th out of 973 stocksDiagnostic Substances Industry8th out of 13 stocks 3.5 Analyst's Opinion Consensus RatingAchieve Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.67, Achieve Life Sciences has a forecasted upside of 334.1% from its current price of $4.30.Amount of Analyst CoverageAchieve Life Sciences has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.32% of the outstanding shares of Achieve Life Sciences have been sold short.Short Interest Ratio / Days to CoverAchieve Life Sciences has a short interest ratio ("days to cover") of 12.2, which indicates bearish sentiment.Change versus previous monthShort interest in Achieve Life Sciences has recently decreased by 2.57%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAchieve Life Sciences does not currently pay a dividend.Dividend GrowthAchieve Life Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ACHV. Previous Next 2.8 News and Social Media Coverage News SentimentAchieve Life Sciences has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Achieve Life Sciences this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for ACHV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Achieve Life Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Achieve Life Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of Achieve Life Sciences is held by insiders.Percentage Held by Institutions43.65% of the stock of Achieve Life Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Achieve Life Sciences are expected to grow in the coming year, from ($1.62) to ($1.61) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Achieve Life Sciences is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Achieve Life Sciences is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAchieve Life Sciences has a P/B Ratio of 9.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Achieve Life Sciences (NASDAQ:ACHV) StockAchieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.Read More ACHV Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ACHV Stock News HeadlinesSeptember 28, 2023 | nj.comCollege Achieve Central beats Roselle Park to extend win streak - Boys soccer recapSeptember 27, 2023 | nj.comCollege Achieve Central beats Rutgers Prep to extend win streak - Boys soccer recapSeptember 30, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...September 26, 2023 | msn.comCollege Achieve Public Schools Named Finalist for 2023 Yass Prize, Aiming to Transform EducationSeptember 22, 2023 | nj.comGirls soccer recap: Gabriela Garcia scores twice as College Achieve tops Lincoln LeadershipSeptember 22, 2023 | nj.comCollege Achieve Central defeats Delaware Valley - Boys soccer recapSeptember 20, 2023 | villagegreennj.comThe Achieve Foundation Newstead 5K is Saturday, September 30September 19, 2023 | usnews.comXi Says China, US 'Should and Must' Achieve Peaceful Co-ExistenceSeptember 30, 2023 | UNKNOWN (Ad)As AI Explodes this Company Could SkyrocketA game-changing device expected to hit the market soon may put this AI company on the map.September 15, 2023 | nj.comSummit shuts out College Achieve Central - Boys soccer recapSeptember 1, 2023 | msn.comExit Realty Achieve: Making Realty A Supportive, Collaborative BusinessAugust 16, 2023 | finance.yahoo.comACHV: 2Q:23 ResultsAugust 16, 2023 | finance.yahoo.comQ2 2023 Achieve Life Sciences Inc Earnings CallAugust 15, 2023 | finance.yahoo.comIndividual investors account for 59% of Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) ownership, while institutions account for 40%August 14, 2023 | finance.yahoo.comAchieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate UpdateAugust 4, 2023 | markets.businessinsider.comAchieve announces close of $214 million, AAA-rated personal loan securitizationAugust 1, 2023 | finance.yahoo.comAchieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and WebcastJuly 18, 2023 | finance.yahoo.comAchieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual MeetingJuly 15, 2023 | finance.yahoo.comACHV - Achieve Life Sciences, Inc.July 12, 2023 | usnews.comLG Elec Says It Aims to Achieve $77 Billion in Sales by 2030July 11, 2023 | finance.yahoo.comAchieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)June 6, 2023 | finance.yahoo.comAchieve Life Sciences Announces Participation at Upcoming Investor ConferencesJune 1, 2023 | msn.comLake Street Maintains Achieve Life Sciences (ACHV) Buy RecommendationMay 31, 2023 | bizjournals.comAchieve Life Sciences raises $16.5M in pursuit of anti-smoking drugMay 25, 2023 | msn.comAchieve Life Sciences stock down on pricing $16.5M stock offeringMay 25, 2023 | finance.yahoo.comACHV: ORCA-3 ToplineMay 25, 2023 | finance.yahoo.comAchieve Life Sciences Announces Pricing of $16.5 Million Registered Direct OfferingSee More Headlines Receive ACHV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address ACHV Company Calendar Last Earnings8/14/2023Today9/29/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryBiotechnology SectorMedical Current SymbolNASDAQ:ACHV CUSIP68230A10 CIK949858 Webachievelifesciences.com Phone(604) 210-2217Fax425-686-1600Employees20Year FoundedN/APrice Target and Rating Average Stock Price Forecast$18.67 High Stock Price Forecast$20.00 Low Stock Price Forecast$17.00 Forecasted Upside/Downside+334.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($3.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,350,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-852.58% Return on Assets-160.68% Debt Debt-to-Equity Ratio1.63 Current Ratio7.65 Quick Ratio7.65 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.46 per share Price / Book9.35Miscellaneous Outstanding Shares21,110,000Free Float20,684,000Market Cap$90.77 million OptionableNot Optionable Beta1.52 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Richard A. B. Stewart (Age 64)Exec. Chairman Comp: $575kMr. John A. Bencich M.B.A. (Age 46)CEO & Director Comp: $733.12kDr. Cindy Jacobs M.D. (Age 65)Ph.D., Pres, Chief Medical Officer & Director Comp: $614.25kMr. Jerry Wan (Age 41)Principal Accounting Officer Dr. Anthony Clarke (Age 67)Chief Scientific Officer Ms. Jaime XinosExec. VP of CommercialMore ExecutivesKey CompetitorsAlpha TeknovaNASDAQ:TKNOVolitionRxNYSE:VNRXAspira Women's HealthNASDAQ:AWHImmuCellNASDAQ:ICCCTrinity BiotechNASDAQ:TRIBView All CompetitorsInsiders & InstitutionsWells Fargo & Company MNSold 2,030 shares on 8/15/2023Ownership: 0.679%XTX Topco LtdBought 14,841 shares on 8/15/2023Ownership: 0.082%Citadel Advisors LLCBought 10,500 shares on 8/15/2023Ownership: 0.000%Prelude Capital Management LLCBought 11,772 shares on 8/14/2023Ownership: 0.150%Tower Research Capital LLC TRC Bought 15,792 shares on 8/14/2023Ownership: 0.108%View All Insider TransactionsView All Institutional Transactions ACHV Stock - Frequently Asked Questions Should I buy or sell Achieve Life Sciences stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACHV shares. View ACHV analyst ratings or view top-rated stocks. What is Achieve Life Sciences' stock price forecast for 2023? 2 equities research analysts have issued 1 year price objectives for Achieve Life Sciences' shares. Their ACHV share price forecasts range from $17.00 to $20.00. On average, they expect the company's share price to reach $18.67 in the next twelve months. This suggests a possible upside of 334.1% from the stock's current price. View analysts price targets for ACHV or view top-rated stocks among Wall Street analysts. How have ACHV shares performed in 2023? Achieve Life Sciences' stock was trading at $2.45 at the beginning of 2023. Since then, ACHV shares have increased by 75.5% and is now trading at $4.30. View the best growth stocks for 2023 here. When is Achieve Life Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our ACHV earnings forecast. How were Achieve Life Sciences' earnings last quarter? Achieve Life Sciences, Inc. (NASDAQ:ACHV) issued its quarterly earnings data on Monday, August, 14th. The biopharmaceutical company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.41) by $0.02. When did Achieve Life Sciences' stock split? Achieve Life Sciences shares reverse split before market open on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Achieve Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI). What is Achieve Life Sciences' stock symbol? Achieve Life Sciences trades on the NASDAQ under the ticker symbol "ACHV." How do I buy shares of Achieve Life Sciences? Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Achieve Life Sciences' stock price today? One share of ACHV stock can currently be purchased for approximately $4.30. How much money does Achieve Life Sciences make? Achieve Life Sciences (NASDAQ:ACHV) has a market capitalization of $90.77 million. The biopharmaceutical company earns $-42,350,000.00 in net income (profit) each year or ($3.11) on an earnings per share basis. How can I contact Achieve Life Sciences? Achieve Life Sciences' mailing address is 1040 WEST GEORGIA STREET SUITE 1030, VANCOUVER BC, V6E 4H1. The official website for the company is achievelifesciences.com. The biopharmaceutical company can be reached via phone at (604) 210-2217, via email at jwong@bplifescience.com, or via fax at 425-686-1600. This page (NASDAQ:ACHV) was last updated on 9/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.